These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26779167)

  • 1. Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus.
    Zhou YF; Shi W; Yu Y; Tao MT; Xiong YQ; Sun J; Liu YH
    Front Microbiol; 2015; 6():1513. PubMed ID: 26779167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
    Yu Y; Zhou YF; Chen MR; Li X; Qiao GL; Sun J; Liao XP; Liu YH
    PLoS One; 2016; 11(5):e0156273. PubMed ID: 27218674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
    Wang J; Shan Q; Ding H; Liang C; Zeng Z
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3008-12. PubMed ID: 24614373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.
    Ahmad I; Hao H; Huang L; Sanders P; Wang X; Chen D; Tao Y; Xie S; Xiuhua K; Li J; Dan W; Yuan Z
    Front Microbiol; 2015; 6():588. PubMed ID: 26136730
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jiang LJ; Xiao X; Yan KX; Deng T; Wang ZQ
    Front Vet Sci; 2022; 9():837882. PubMed ID: 35350432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kill Rate and Evaluation of
    Zhang L; Xie H; Wang H; Ding H; Zhang G; Hu J
    Front Vet Sci; 2021; 8():751957. PubMed ID: 34966804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.
    Xiong M; Wu X; Ye X; Zhang L; Zeng S; Huang Z; Wu Y; Sun J; Ding H
    Front Microbiol; 2016; 7():874. PubMed ID: 27375594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against
    Zhang L; Zhou Z; Gu X; Huang S; Shen X; Ding H
    Front Vet Sci; 2020; 7():448. PubMed ID: 32851028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
    Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
    BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
    Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
    Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.
    Xiao X; Chen X; Yan K; Jiang L; Li R; Liu Y; Wang M; Wang Z
    J Vet Pharmacol Ther; 2022 Jan; 45(1):83-91. PubMed ID: 34469000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals.
    Lee DH; Birhanu BT; Lee EB; Lee SJ; Boby N; Park YS; Park SC
    Vet Res; 2020 Oct; 51(1):131. PubMed ID: 33059768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of
    Yu Y; Zhou YF; Li X; Chen MR; Qiao GL; Sun J; Liao XP; Liu YH
    Front Microbiol; 2016; 7():1595. PubMed ID: 27774090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
    Lepak AJ; Marchillo K; Craig WA; Andes DR
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activity of cefquinome against Escherichia coli in the thighs of neutropenic mice.
    Shan Q; Liang C; Wang J; Li J; Zeng Z
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5943-6. PubMed ID: 25070101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
    Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
    Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates.
    Mandell JB; Orr S; Koch J; Nourie B; Ma D; Bonar DD; Shah N; Urish KL
    J Orthop Res; 2019 Jul; 37(7):1604-1609. PubMed ID: 30919513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.